Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 2-(diphenylamino)-n-(7-(hydroxyamino)-7-oxoheptyl)pyrimidine-5-carboxamide
2. Acy-1215
3. Rocilinostat
1. 1316214-52-4
2. Acy-1215
3. Rocilinostat
4. 2-(diphenylamino)-n-(7-(hydroxyamino)-7-oxoheptyl)pyrimidine-5-carboxamide
5. Rocilinostat (acy-1215)
6. Acy-63
7. Ricolinostat (acy-1215)
8. N-[7-(hydroxyamino)-7-oxoheptyl]-2-(n-phenylanilino)pyrimidine-5-carboxamide
9. Wkt909c62b
10. 7-{[2-(diphenylamino)pyrimidin-5-yl]formamido}-n-hydroxyheptanamide
11. Mfcd22666356
12. 2-(diphenylamino)-n-[7-(hydroxyamino)-7-oxoheptyl]pyrimidine-5-carboxamide
13. 5-pyrimidinecarboxamide, 2-(diphenylamino)-n-(7-(hydroxyamino)-7-oxoheptyl)-
14. Ricolinostat [usan]
15. Ricolinostat [usan:inn]
16. Unii-wkt909c62b
17. 5-pyrimidinecarboxamide, 2-(diphenylamino)-n-[7-(hydroxyamino)-7-oxoheptyl]-
18. Acy1215
19. Ricolinostat (usan/inn)
20. Ricolinostat [inn]
21. 2-(diphenylamino)-n-[7-(hydroxyamino)-7-oxoheptyl]-5-pyrimidinecarboxamide
22. Mls006011181
23. Ricolinostat [who-dd]
24. Schembl574580
25. Gtpl7010
26. Chembl2364628
27. Chebi:95073
28. Dtxsid40157148
29. Ex-a139
30. Hms3426c09
31. Hms3653f17
32. Hms3886l21
33. Acy 1215
34. Amy38185
35. Bcp06028
36. Bdbm50439674
37. Nsc767952
38. S8001
39. Zinc89630354
40. Akos024259260
41. Ccg-269054
42. Cs-0965
43. Db12376
44. Nsc-767952
45. Sb17054
46. Ncgc00345802-01
47. Ncgc00345802-05
48. Ac-30258
49. As-73344
50. Ba164806
51. Hy-16026
52. Smr004702950
53. Sy096614
54. Sw219836-1
55. D10661
56. J-690127
57. Q27088553
58. Ah4
59. Us8609678, 2-(diphenylamino)-n-(7-(hydroxyamino)-7-oxoheptyl)pyrimidine-5-carboxamide [26]
Molecular Weight | 433.5 g/mol |
---|---|
Molecular Formula | C24H27N5O3 |
XLogP3 | 3.4 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 11 |
Exact Mass | 433.21138974 g/mol |
Monoisotopic Mass | 433.21138974 g/mol |
Topological Polar Surface Area | 107 Ų |
Heavy Atom Count | 32 |
Formal Charge | 0 |
Complexity | 538 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Antineoplastic Agents
Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)
Histone Deacetylase Inhibitors
Compounds that inhibit HISTONE DEACETYLASES. This class of drugs may influence gene expression by increasing the level of acetylated HISTONES in specific CHROMATIN domains. (See all compounds classified as Histone Deacetylase Inhibitors.)
ABOUT THIS PAGE
87
PharmaCompass offers a list of Ricolinostat API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ricolinostat manufacturer or Ricolinostat supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ricolinostat manufacturer or Ricolinostat supplier.
PharmaCompass also assists you with knowing the Ricolinostat API Price utilized in the formulation of products. Ricolinostat API Price is not always fixed or binding as the Ricolinostat Price is obtained through a variety of data sources. The Ricolinostat Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Ricolinostat manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ricolinostat, including repackagers and relabelers. The FDA regulates Ricolinostat manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ricolinostat API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Ricolinostat supplier is an individual or a company that provides Ricolinostat active pharmaceutical ingredient (API) or Ricolinostat finished formulations upon request. The Ricolinostat suppliers may include Ricolinostat API manufacturers, exporters, distributors and traders.
Ricolinostat Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ricolinostat GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ricolinostat GMP manufacturer or Ricolinostat GMP API supplier for your needs.
A Ricolinostat CoA (Certificate of Analysis) is a formal document that attests to Ricolinostat's compliance with Ricolinostat specifications and serves as a tool for batch-level quality control.
Ricolinostat CoA mostly includes findings from lab analyses of a specific batch. For each Ricolinostat CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ricolinostat may be tested according to a variety of international standards, such as European Pharmacopoeia (Ricolinostat EP), Ricolinostat JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ricolinostat USP).